Chimerix News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

09.06.15	OCLS Gets A Facelift, NBIX Halts Trials, CBYL For The Long Haul, CMRX On Track (RTTNews)
27.02.15	STAR Lights Up CYTX, NVAX Awaits Catalysts, VTAE Thrashed, CMRX On Watch (RTTNews)
13.02.15	ADHD Needs Your Attention, MOH In Good Health, GNCA Awaits Catalysts (RTTNews)
02.02.15	Shire's Vyvanse Gets Attention, CMRX Bids Adieu To Ebola Trials, VTL On Watch (RTTNews)
01.02.15	Chimerix To Cease Participation In Clinical Studies Of Ebola Drug (RTTNews)
08.10.14	Chimerix' Brincidofovir Shows Potential Survival Benefit In Adenovirus Infection (RTTNews)
07.10.14	ACT Opens Wallet, ADHD Craters, CMRX Focuses On Ebola, REGN Gets FDA Nod (RTTNews)
06.10.14	Chimerix Announces Emergency Investigational NDA For Brincidofovir (RTTNews)
07.08.14	Chimerix Net Loss Reduces In Q2 - Quick Facts (RTTNews)
21.05.14	Chimerix Prices Public Offering Of 7.3 Mln Shares At $14.22/Shr - Quick Facts (RTTNews)
19.05.14	Chimerix Announces Public Offering Of 6.2 Mln Shares (RTTNews)
16.05.14	Chimerix Regains Worldwide Rights To CMX157 From Merck - Quick Facts (RTTNews)
09.05.14	Chimerix Posts Wider-than-expected Q1 Loss; Revenues Miss - Quick Facts (RTTNews)
09.04.14	Chimerix CEO Resigns, Names Replacement (RTTNews)
07.03.14	Chimerix Q4 Loss Widens - Quick Facts (RTTNews)
14.11.13	Chimerix Slips To Loss In Q3 - Quick Facts (RTTNews)
26.09.13	Chimerix Reports Positive Phase 2 Results Of Brincidofovir - Quick Facts (RTTNews)
09.09.13	Chimerix Begins Dosing In Phase 3 SUPPRESS Trial Of Brincidofovir (RTTNews)
14.08.13	Chimerix Reports Encouraging Results From CMX001 Phase 2 Adenovirus Trial (RTTNews)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

CieFinRichemont	137.35	1.40 %	K V
Sonova Hldg	297.30	1.29 %	K V
Logitech Intl	74.86	1.22 %	K V
Nestle	75.22	1.02 %	K V
Alcon	76.32	0.95 %	K V
UBS Group	28.17	-0.67 %	K V
Swiss Re	131.95	-0.68 %	K V
Geberit	533.80	-0.78 %	K V
Lonza Grp	541.40	-0.81 %	K V
Kuehne+Nagel Int	202.60	-1.65 %	K V